Search

Lonza Group AG

Gesloten

SectorGezondheidszorg

569.79 1.49

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

561.4

Max

573.6

Belangrijke statistieken

By Trading Economics

Inkomsten

88M

571M

Verkoop

419M

3.4B

K/W

Sectorgemiddelde

35.407

55.725

Dividendrendement

0.92

Winstmarge

16.924

Werknemers

20,141

EBITDA

321M

1.1B

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+25.57% upside

Dividenden

By Acuity

Dividendrendement

Sectorgemiddelde

0.92%

2.25%

Volgende Winsten

14 okt 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-1.1B

38B

Vorige openingsprijs

568.3

Vorige sluitingsprijs

569.79

Nieuwssentiment

By Acuity

48%

52%

125 / 339 Rangschikking in Healthcare

Lonza Group AG Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

23 sep 2026, 23:31 UTC

News
Social Media

Amazon.com Inc. is declining in after-market trading amid rising Treasury yields and geopolitical tensions, contributing to broader market downturns.

23 sep 2026, 23:31 UTC

News

BWX Technologies Inc. received a BBB investment grade credit rating from Fitch Ratings, boosting after-market trading modestly higher.

23 sep 2026, 23:31 UTC

Correlated Moves
News
Event

H.B. Fuller reported Q3 2026 net revenue of $938 million and adjusted EPS of $1.52, exceeding estimates, and traded higher in after-market hours.

23 sep 2026, 23:26 UTC

Social Media
News

Robinhood Markets Inc. is trading slightly higher in after-market hours, bolstered by 13 revenue streams each generating over $100 million annually and positive growth forecasts.

23 sep 2026, 23:25 UTC

News

Kraft Heinz Co is trading higher in after-market hours following RBC Capital Markets' "Outperform" rating and $32 price target, projecting 0.9% revenue growth by 2027.

23 sep 2026, 23:21 UTC

News
Social Media

Meta Platforms Inc. is trading lower after-hours despite the launch of its Muse AI personal agent, which has garnered significant social media attention.

23 sep 2026, 23:20 UTC

News

Goldman Sachs is selling Applied Systems, valued at up to $10 billion, as its stock moves higher in after-market trading amid active investment banking.

23 sep 2026, 23:20 UTC

News

DoorDash Inc plans to pay $131.5 million to settle worker underpayment allegations, with its stock trading lower in after-market hours following the announcement.

23 sep 2026, 23:16 UTC

News

Ethereum is trading lower, diverging from recent gains, amid rising U.S. crude oil inventories and strong economic data indicating robust private sector growth.

23 sep 2026, 23:15 UTC

Social Media
News

Gossamer Bio Inc has submitted a New Drug Application for seralutinib targeting pulmonary arterial hypertension, with shares advancing in after-market trading.

23 sep 2026, 23:15 UTC

News

Cooper Companies Inc's stock declines in after-market trading following a $30 million revenue miss in Q3, despite announcing a new global innovation hub in England.

23 sep 2026, 23:15 UTC

News

AutoNation Inc announced a $1 million investment in cancer research grants, with its stock advancing modestly in after-market trading following the announcement.

23 sep 2026, 23:11 UTC

Correlated Moves
News

The USD/SEK is advancing modestly as the U.S. dollar strengthens amid signals of potential Federal Reserve rate hikes to combat inflation.

23 sep 2026, 23:06 UTC

News

UPS shares are slightly higher in after-market trading amid scrutiny over the diversion of sensitive F-35 parts to Hong Kong by the Chinese government.

23 sep 2026, 23:06 UTC

Correlated Moves
News

Lockheed Martin's stock has gained in after-market hours following reports of the Chinese government seizing sensitive F-35 parts during shipment from Australia to the U.S.

23 sep 2026, 23:06 UTC

Correlated Moves
News

Wells Fargo shares are modestly higher in after-market trading following the announcement of Chief Risk Officer Derek Flowers' upcoming retirement in mid-January.

23 sep 2026, 23:06 UTC

Social Media
News

McDonald's is exploring menu growth opportunities for households using GLP-1 medications, with plans to reintroduce salads and grilled chicken items, gaining in after-market trading.

23 sep 2026, 23:05 UTC

News

Lennar Corp. announced a quarterly dividend of $0.50 per share and reported increased stake from Berkshire Hathaway, with shares trading higher in after-market hours.

23 sep 2026, 23:05 UTC

News

Altria Group Inc. is experiencing a decline in after-market trading amid potential regulatory changes for smoke-free nicotine products, raising concerns among public health advocates.

23 sep 2026, 23:05 UTC

News

PepsiCo announced a significant order for 10k electric trucks through the ZET SCALE alliance, while its stock traded roughly flat in after-market hours.

23 sep 2026, 23:05 UTC

News

Verizon grants $1 million to Liberty Science Center for AI initiative.

23 sep 2026, 23:05 UTC

News

The USD/NOK is advancing modestly as U.S. crude oil inventories rose by 2.969 million barrels, raising supply concerns affecting the Norwegian krone.

23 sep 2026, 23:05 UTC

News

General Mills Inc reports Q1 fiscal 2027 results with improved dollar sales and strong e-commerce growth, trading slightly higher in after-market hours.

23 sep 2026, 23:01 UTC

News

Regenxbio Inc. has settled patent litigation with Sarepta Therapeutics, receiving $39 million, leading to a rise in after-market trading.

23 sep 2026, 23:01 UTC

News

TransUnion shares are trading lower after CFO Todd Cello announced his planned departure at the end of 2026, despite reaffirmed financial guidance.

23 sep 2026, 23:01 UTC

Correlated Moves
News

JPMorgan Chase & Co is involved in the sale of Applied Systems, valued at up to $10 billion, and is modestly higher in after-market trading.

23 sep 2026, 23:01 UTC

News

AbbVie Inc. is down slightly in after-market trading, pulling back from an earlier session high, with a "Sell" rating and a price target of $191.

23 sep 2026, 23:01 UTC

News
Social Media

MGM Resorts International's stock is sharply lower after Barry Diller withdrew his $18 billion acquisition bid, reaffirming the company's standalone commitment.

23 sep 2026, 23:01 UTC

News

Arcturus Therapeutics announced positive interim Phase 2 results for ARCT-810 and unveiled its LUNAR 2.0 platform, yet the stock is trading lower in after-market hours.

23 sep 2026, 23:01 UTC

News

The USD/THB is advancing, reaching its highest cumulative return amid strong U.S. private sector growth, with the S&P Global Composite PMI rising to 58.4.

Peer Vergelijking

Prijswijziging

Lonza Group AG Prognose

Koersdoel

By TipRanks

25.57% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 705.429 CHF  25.57%

Hoogste 781 CHF

Laagste 640 CHF

Gebaseerd op 8 Wall Street-analisten die 12-maands prijsdoelen bieden voor Lonza Group AG - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

8 ratings

8

Buy

0

Hold

0

Sell

Sentiment

By Acuity

125 / 339 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Lonza Group AG

Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments. The Biologics segment engages in the contract development and manufacturing of biopharmaceuticals for clinical and commercial manufacturing needs throughout the product lifecycle, including drug substance and drug product manufacturing. The Small Molecules segment operates as an integrated development and manufacturing service provider for small molecule drug substances and their intermediates. This segment also supports customers across various aspects of design, development, and manufacturing, including particle engineering and drug product packaging. The Cell & Gene segment develops technologies and platforms that industrialize the manufacturing processes and production of cell and gene therapies; offers contract development and manufacturing services, and regulatory support for a range of allogeneic and autologous cell therapies, and exosome-based therapies, as well as viral vector gene therapies. This segment also provides Cocoon platform, a closed automated system for patient-scale cell therapy manufacturing; and specialty raw materials and enabling technology solutions in cell and gene therapy, injectable drugs, vaccines, and bio-manufacturing markets. The Capsules & Health Ingredients segment offers capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical customers. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.